A Study of SHR-3821 Injection in Subjects With Advanced Solid Tumors

Clinical trial NCT06618651 · RECRUITING

Trial details

NCT number: NCT06618651
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2024-11-13
Primary completion: 2026-01-01
Enrollment: 162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.